TY - JOUR
T1 - Drug-Repositioning Approaches Based on Medical and Life Science Databases
AU - Zamami, Yoshito
AU - Hamano, Hirofumi
AU - Niimura, Takahiro
AU - Aizawa, Fuka
AU - Yagi, Kenta
AU - Goda, Mitsuhiro
AU - Izawa-Ishizawa, Yuki
AU - Ishizawa, Keisuke
N1 - Funding Information:
This work is the result of research that was supported by the Japan Society for the Promotion of Science KAKENHI grants (20H05798 and 18K06785 to YZ).
Publisher Copyright:
Copyright © 2021 Zamami, Hamano, Niimura, Aizawa, Yagi, Goda, Izawa-Ishizawa and Ishizawa.
PY - 2021/11/1
Y1 - 2021/11/1
N2 - Drug repositioning is a drug discovery strategy in which an existing drug is utilized as a therapeutic agent for a different disease. As information regarding the safety, pharmacokinetics, and formulation of existing drugs is already available, the cost and time required for drug development is reduced. Conventional drug repositioning has been dominated by a method involving the search for candidate drugs that act on the target molecules of an organism in a diseased state through basic research. However, recently, information hosted on medical information and life science databases have been used in translational research to bridge the gap between basic research in drug repositioning and clinical application. Here, we review an example of drug repositioning wherein candidate drugs were found and their mechanisms of action against a novel therapeutic target were identified via a basic research method that combines the findings retrieved from various medical and life science databases.
AB - Drug repositioning is a drug discovery strategy in which an existing drug is utilized as a therapeutic agent for a different disease. As information regarding the safety, pharmacokinetics, and formulation of existing drugs is already available, the cost and time required for drug development is reduced. Conventional drug repositioning has been dominated by a method involving the search for candidate drugs that act on the target molecules of an organism in a diseased state through basic research. However, recently, information hosted on medical information and life science databases have been used in translational research to bridge the gap between basic research in drug repositioning and clinical application. Here, we review an example of drug repositioning wherein candidate drugs were found and their mechanisms of action against a novel therapeutic target were identified via a basic research method that combines the findings retrieved from various medical and life science databases.
KW - database
KW - drug repositioning
KW - existing drugs
KW - life science databases
KW - medical information database
UR - http://www.scopus.com/inward/record.url?scp=85119146015&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85119146015&partnerID=8YFLogxK
U2 - 10.3389/fphar.2021.752174
DO - 10.3389/fphar.2021.752174
M3 - Review article
AN - SCOPUS:85119146015
SN - 1663-9812
VL - 12
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
M1 - 752174
ER -